IRIS
CALABRESE, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.063
AS - Asia 2.775
EU - Europa 2.104
SA - Sud America 581
AF - Africa 160
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.941
SG - Singapore 896
RU - Federazione Russa 829
CN - Cina 712
IT - Italia 560
BR - Brasile 463
VN - Vietnam 306
KR - Corea 220
HK - Hong Kong 195
IE - Irlanda 168
BD - Bangladesh 155
IN - India 112
FI - Finlandia 91
NL - Olanda 87
ZA - Sudafrica 85
DE - Germania 81
FR - Francia 80
GB - Regno Unito 67
CA - Canada 61
MX - Messico 38
AR - Argentina 36
CI - Costa d'Avorio 30
KE - Kenya 25
AT - Austria 23
EC - Ecuador 22
ES - Italia 22
JP - Giappone 22
IQ - Iraq 20
PL - Polonia 18
SE - Svezia 18
ID - Indonesia 16
TR - Turchia 16
SA - Arabia Saudita 13
CO - Colombia 12
CL - Cile 11
PK - Pakistan 10
PY - Paraguay 10
VE - Venezuela 10
CZ - Repubblica Ceca 9
LT - Lituania 9
MY - Malesia 8
JO - Giordania 7
PH - Filippine 7
IR - Iran 6
PE - Perù 6
PT - Portogallo 6
UY - Uruguay 6
CH - Svizzera 5
PS - Palestinian Territory 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
NP - Nepal 4
PA - Panama 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
MK - Macedonia 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
TW - Taiwan 3
UA - Ucraina 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
NG - Nigeria 2
OM - Oman 2
QA - Qatar 2
SI - Slovenia 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GQ - Guinea Equatoriale 1
GT - Guatemala 1
Totale 14.672
Salva come PNG Salva come JPEG
Città #
Dallas 7.592
Singapore 518
Hefei 340
Moscow 248
Seoul 216
Santa Clara 187
Hong Kong 185
Dublin 167
Beijing 147
Ashburn 131
San Jose 121
Ho Chi Minh City 114
Milan 104
Los Angeles 85
Siena 76
Council Bluffs 75
Johannesburg 73
Hanoi 70
The Dalles 61
Lauterbourg 52
Helsinki 48
New York 48
Bengaluru 45
São Paulo 40
Haarlem 38
Florence 35
Buffalo 34
Abidjan 30
Munich 29
Rome 29
Lappeenranta 28
Chicago 27
Redondo Beach 22
Nuremberg 21
Orem 21
Chennai 17
Rio de Janeiro 17
Frankfurt am Main 15
Mexico City 15
Turku 15
Amsterdam 14
Naples 14
Toronto 13
Warsaw 13
Da Nang 12
Guayaquil 12
Houston 12
Hyderabad 12
London 12
Atlanta 11
Haiphong 11
Salt Lake City 11
Stockholm 11
Vienna 11
Brooklyn 10
Columbus 10
Montreal 10
Tokyo 10
Brno 9
Genoa 9
Manchester 9
Baghdad 8
Catania 8
Denver 8
Poplar 8
Bari 7
Bologna 7
Brasília 7
Ceggia 7
Charlotte 7
Curitiba 7
Hải Dương 7
Mumbai 7
Querétaro 7
Thái Bình 7
Amman 6
Belo Horizonte 6
Clifton 6
Goiânia 6
Guarulhos 6
Miami 6
Ottawa 6
Paris 6
Pisa 6
Recife 6
Salvador 6
Seravezza 6
São Gonçalo 6
Tampa 6
Tehran 6
Ancona 5
Asunción 5
Biên Hòa 5
Calgary 5
Düsseldorf 5
Ha Long 5
Hillsboro 5
Lima 5
Modena 5
Nairobi 5
Totale 11.614
Salva come PNG Salva come JPEG
Nome #
009 The transcriptome of Sweet syndrome suggests a pathogenic role of both innate and adaptive immune signaling pathways 7.213
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study 237
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study 211
Advances in the Pathogenesis and Treatment of Rosacea: A Phenotype-Based Therapeutic Approach 207
MAPK15 controls cellular responses to oxidative stress by regulating NRF2 activity and expression of its downstream target genes 193
Pso-Reg: a web registry for psoriasis in real life 176
Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a "real-world", mono-center experience 175
Baricitinib: therapeutic potential for moderate to severe atopic dermatitis 171
Risk of Skin Cancer in Patients with Psoriasis: Single-Center Retrospective Study Comparing Anti-TNFα and Phototherapy 158
Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris 155
Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition 152
Eyelid contact dermatitis: 25-year single-center retrospective study 151
Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose? 150
Line-field confocal optical coherence tomography for the diagnosis of skin carcinomas: real-life data over three years 144
Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin 142
Characteristics of primary cutaneous lymphoma in Italy: a tertiary care, single-center study 141
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous Lymphomas 140
Diffuse purpuric pityriasis versicolor: a peculiar presentation 136
Clinical response to brodalumab in a patient affected by refractory SAPHO syndrome 135
Italian Consensus on the treatment of oral lichen planus 135
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still's Disease Registry 134
Characterisation of IL-1 family members in Sweet syndrome highlights the overexpression of IL-1β and IL-1R3 as possible therapeutic targets 133
Erfolgreiche Behandlung des therapierefraktären Sweet-Syndroms mit Adalimumab 129
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice 129
Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease 127
Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases* 119
Short-, mid- and long-term efficacy of dupilumab in moderate to severe atopic dermatitis: a real life multicenter Italian study on 2576 patients 119
Efficacy and safety of biologics for hidradenitis suppurativa: A network meta-analysis of phase III trials 116
Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma 116
Molecular Characteristics of Sweet Syndrome: A Systematic Review 115
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa 114
Erythema annulare centrifugum as clinical manifestation of-eosinophilic granulomatosis with polyangiitis 113
Belimumab as a potential therapeutic option for bullous systemic lupus erythematosus 113
Line-field confocal optical coherence tomography in alopecia areata and histopathological correlation 112
Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg? 112
Psoriasis and fibromyalgia: a systematic review 111
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 109
Psoriasis and its management in women of childbearing age: tools to increase awareness in dermatologists and patients 108
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa 106
Investigational systemic drugs for moderate to severe plaque psoriasis: What’s new? 106
Use of JAK Inhibitors in Lichen Planus: An Update 105
The corkscrew hairs of tinea capitis through line-field confocal optical coherence tomography 103
Overview of Atopic Dermatitis in Different Ethnic Groups 103
Fibromyalgia and Skin Disorders: A Systematic Review 101
Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis 101
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 100
Tildrakizumab in moderate-to-severe plaque psoriasis: a multicenter, retrospective, real-life study 99
Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients 99
The role of NLRP1 inflammasome in skin cancer and inflammatory skin diseases 99
Sweet syndrome: an update on clinical aspects, pathophysiology, and treatment 98
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis 97
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies 96
725 Characterizing the transcriptional landscape of pyoderma gangrenosum and its main differential diagnoses 91
Severe and resistant palmar psoriasis successfully treated with risankizumab 90
Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses 89
Design and development of a systematic validation protocol for synthetic melanoma images for responsible use in medical artificial intelligence 89
Hyper-IgD syndrome and hidradenitis suppurativa: an intriguing link 89
From Bank Preparation to Clinical Use of Homologous Skin Allografts in Wound Healing: A Sustainable Approach 89
Successful treatment of pyoderma gangrenosum with composite grafting of acellular dermal matrix and glycerolized skin: a preliminary experience 83
Recalcitrant Sweet Syndrome successfully treated with adalimumab 82
Novel therapeutic strategies in the topical treatment of atopic dermatitis 77
Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study 74
117 Indiscernible skin transcriptome in Stevens-Johnson syndrome and toxic epidermal necrolysis induced by immune checkpoint inhibitors and other culprit drugs 68
Upadacitinib for Treatment-Resistant Urticarial Vasculitis: A Case Study and Therapeutic Insight 67
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry 60
T2-Reg: a regional web registry on Th2-mediated diseases 39
High-throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid 30
Abrocitinib: 1-Year Real-Life Experience From the French OMCCI Registry 18
Totale 14.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20232 0 0 0 0 0 0 0 0 0 0 0 2
2023/2024511 2 1 1 125 41 61 113 15 26 29 50 47
2024/20252.005 39 80 188 104 190 72 64 141 148 144 169 666
2025/202612.481 427 2.481 5.824 891 805 181 483 234 209 359 353 234
Totale 14.999